ATLANTA — Azurity Pharmaceuticals has issued a recall for a specific lot of its ADHD and narcolepsy medication, Zenzedi, due to a packaging error that resulted in the inclusion of incorrect pills.
The recall notice, released on Wednesday, states that one lot of Zenzedi 30 milligram tablets is being recalled after a pharmacist discovered tablets of carbinoxamine maleate, an antihistamine, in a bottle labeled as Zenzedi.
This recall comes at a time when there is a national shortage of ADHD drugs, which has been ongoing since October 2022. This shortage has added to the confusion and unpredictability for individuals with ADHD who have been struggling to access their necessary medications.
Zenzedi contains dextroamphetamine sulfate, a stimulant used for the treatment of ADHD and narcolepsy. On the other hand, carbinoxamine maleate, the allergy drug found in the mislabeled bottles, is a sedative and has the opposite effect of a stimulant, according to the Mayo Clinic.
Individuals who mistakenly take carbinoxamine instead of Zenzedi are at a higher risk of accidents or injuries and may experience drowsiness, increased eye pressure, urinary obstruction, and thyroid disorder, as stated in the recall notice.
The recalled lot is identified by the lot number F230169A and has an expiration date of June 2025. Azurity has confirmed that there have been no reports of serious injury related to the medication mix-up.
Consumers who have the recalled medication are advised to return it to their pharmacy immediately and to contact their health care provider if they experience any adverse reactions to the drug.
Any issues can also be reported to the FDA’s MedWatch Adverse Event Reporting program.
It is crucial for individuals to be aware of this recall and take appropriate action to ensure their safety and well-being.
Mix-up of pills leads to recall of ADHD medication.
Disagree – This is a serious mistake that could have harmful consequences. The pharmaceutical company should be held accountable for their negligence.
Disagree – This is a major concern and the pharmaceutical company must take responsibility for their potentially dangerous error.
Agree – This mistake puts people’s health at risk and the pharmaceutical company needs to fix it immediately.